Showing results (381-390 of 539) with videos related to
Sort By:
Pageof 54
Cancer|August 1, 1993
Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age, and extent of diseaseG M Swanson, N E Ragheb, C S Lin, et al.Physical Review Letters|June 4, 2008
Resonant electron heating and molecular phonon cooling in single C60 junctionsG Schulze, K J Franke, A Gagliardi, et al.Nature Genetics|October 1, 1993
De novo expansion of a (CAG)n repeat in sporadic Huntington's diseaseR H Myers, M E MacDonald, W J Koroshetz, et al.The Journal of Experimental Medicine|March 1, 1993
Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activationC S Lin, R C Boltz, J T Blake, et al.The International Journal of Neuropsychopharmacology|August 2, 2012
Monoamine oxidase A and A/B knockout mice display autistic-like featuresMarco Bortolato, Sean C Godar, Loai Alzghoul, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 20, 2016
Enhancement of the genotoxicity of benzo[a]pyrene by arecoline through suppression of DNA repair in HEp-2 cellsJ L Huang, H H Lu, Y N Lu, et al.British Journal of Anaesthesia|June 20, 2015
Chronic intrathecal infusion of mibefradil, ethosuximide and nickel attenuates nerve ligation-induced pain in ratsY L Chen, M L Tsaur, S W Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Perinatal antidepressant exposure alters cortical network function in rodentsKimberly L Simpson, Kristin J Weaver, Etienne de Villers-Sidani, et al.International Journal of Clinical Practice. Supplement|December 25, 2004
A double-blind comparison of the efficacy and tolerability of telmisartan 40-80 mg vs. losartan 50-100 mg in Taiwanese hypertensive patientsY T Lee, C M Lee, C S Lin, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 27, 2010
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)F Vincenti, B Charpentier, Y Vanrenterghem, et al.Pageof 54